Sorrento Therapeutics, Inc. 13D and 13G filings for Celularity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-05 5:22 pm Sale | 2023-09-29 | 13G | Celularity Inc. CELU | Sorrento Therapeutics Inc. SRNEQ | 505,043 2.600% | -1,537,170 (-75.27%) | Filing |
| 2021-07-23 06:02 am Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | Sorrento Therapeutics Inc. SRNEQ | 2,042,212 16.700% | 2,042,212 (New Position) | Filing |